Blog

Comprehensive Workflow for Eligibility and Prior Authorization of Wegovy and Zepound

When a provider prescribes GLP‑1 medications like Wegovy (semaglutide) or Zepbound (tirzepatide) for weight management, it’s not just about handing over a script. Insurance companies usually require extensive eligibility checks and prior authorization (PA) to approve these high-cost medications. If that process isn’t followed to the letter? Expect denials, delays, and frustrated patients.

In this guide, we’ll walk through the full workflow of verifying insurance eligibility and submitting PA requests for GLP‑1 drugs Staffingly-style. From intake to final approval, we’ll use Patient Y, a fictional adult with obesity and type 2 diabetes, as our running example. You’ll see how Virtual Medical Assistants (VMAs) and clinic teams tag-team every detail to get these meds covered efficiently and correctly.

 What Is Prior Authorization (and Why Is It Needed for Wegovy/Zepbound)?

Prior authorization (PA) is the insurance company’s way of saying:

“Convince us this patient really needs this medication, and show us you’ve followed our rules first.”

For GLP‑1s like Wegovy and Zepbound, insurance plans often require:

• Verified BMI criteria (usually ≥30, or ≥27 with comorbidities)

• Proof of failed weight-loss attempts (diet/exercise/lifestyle)

• Documentation of any prior medications tried

• Details of comorbidities (diabetes, hypertension, sleep apnea, etc.)

• A formal PA form or ePA submission, reviewed by their team

Skipping these steps = fast-track to a denial.

 When Does the Workflow Start?

It starts as soon as the provider recommends the medication. Ideally, your team begins pulling clinical and insurance data that same day—even before sending the prescription to the pharmacy.

There are two key parts to the workflow:

1. Insurance Eligibility Verification – Is the patient covered, and is this drug part of the plan’s formulary?

2. Prior Authorization – Can we prove the patient meets the plan’s clinical criteria for approval?

Let’s walk through it, step by step, using Patient Y.

 Step-by-Step Workflow for GLP‑1 Prior Authorization

 Step 1: Intake & Eligibility Pre-Screen

The provider identifies Patient Y as a candidate for Wegovy. Here’s what Staffingly’s VMA does:

• Confirms patient’s height, weight, BMI

• Notes comorbid conditions (e.g., type 2 diabetes, hypertension)

• Asks if the patient has tried prior methods (diet, coaching, weight-loss meds)

• Collects insurance card & details

• Flags any special consent forms required for contacting payers

 Tip: If the BMI is under 27, or there are no comorbidities, PA will likely be denied. The VMA flags this for provider review.

Step 2: Verify Insurance Coverage & Pharmacy Benefits

The VMA logs into Availity or the payer’s portal to:

• Confirm active insurance status

• Check if Wegovy or Zepbound is on formulary

• Note if a prior authorization is required

• Check for step therapy rules (e.g., must try Saxenda first?)

• Get rep name + reference number if calling

If the drug is excluded (some employer plans exclude weight-loss meds), the VMA alerts the provider and patient before wasting time on a PA.

Step 3: Gather Clinical Documentation

To support the PA, the VMA assembles:

• Most recent weight/BMI records

• ICD-10 diagnosis (e.g. E66.01 – morbid obesity)

• Comorbidities (e.g., E11.9 for diabetes)

• History of prior weight-loss efforts (e.g. 6 months with a nutritionist)

• Provider’s clinical note indicating medical necessity

• Any documentation of prior medications used or failed (e.g., Saxenda, phentermine)

 Tip: A strong Letter of Medical Necessity from the provider goes a long way. The VMA often drafts this for signature.

Step 4: Complete and Submit the Prior Authorization

Depending on the insurer, the VMA:

• Logs into CoverMyMeds or a payer-specific portal

• Uploads all documentation

• Fills out drug details: Wegovy 2.4 mg weekly, NDC, start date, etc.

• Ensures provider signs or attests as needed

• Submits via portal or fax (if required), and keeps a copy

 Pro move: The VMA documents submission time, method, confirmation number, and attaches all PA paperwork to the chart.

Step 5: Monitor Status and Follow Up

Now the clock starts ticking. Most plans respond within 5–15 business days.
The VMA will:

• Check the portal or call every 2–3 days

• Respond to any requests for more documentation

• Alert the provider if a peer-to-peer review is offered

• Notify patient of status (especially if denied or delayed)

 Tip: Appeals get messy so clean, complete submission the first time is critical.

Step 6: If Approved…

• VMA confirms approval number, start date, limits

• Ensures the specialty pharmacy has everything needed

• Informs patient of pickup/delivery steps

• Schedules 3-month follow-up visit to document weight loss

• Adds calendar reminder to renew PA (most plans require renewal after 3–6 months with proof of weight loss ≥5%)

 Win: The process ends when medication is delivered and first dose is scheduled!

If Denied…

• VMA pulls denial letter/reason

• Flags the provider and drafts an appeal letter (if appropriate)

• Resubmits with any missing evidence (e.g., prior program dates)

• Coordinates external review or peer-to-peer if available

• Keeps the patient in the loop with empathy: “We’re working on it.”

Some denials can’t be overturned (e.g., drug class not covered), but many succeed on appeal if properly documented.

Why This Process Matters?

• For Providers: Prevents denials, saves hours of rework, and ensures faster payment

• For Patients: Avoids surprise bills, clarifies expectations, and builds trust

• For the Clinic: Keeps revenue flowing, keeps patients compliant, and reduces front desk chaos

Most importantly—it allows patients like Patient Y to start a medication that can drastically improve health outcomes, safely and affordably.

When it comes to GLP‑1 drugs like Wegovy and Zepbound, success is all in the setup. Staffingly’s end-to-end workflow from checking insurance to crafting bulletproof PAs ensures that patients who need these medications aren’t blocked by red tape.

By making this process part of your everyday clinical operations—and giving VMAs clear ownership—you can dramatically increase approval rates, reduce staff burnout, and keep your focus where it belongs: helping patients reach better health outcomes.

What people are asking?

1. Why do Wegovy and Zepbound require prior authorization?
Because they’re high-cost medications, most insurers need proof that the patient meets strict criteria before approving coverage.

2. What documents are needed for the PA?
BMI, comorbidities, prior weight-loss attempts, diagnosis codes, and a provider’s note explaining medical necessity.

3. How long does it take to get approval?
Most insurers respond within 5–15 business days, but delays can happen if paperwork is incomplete.

4. What happens if the PA is denied?
An appeal can be submitted with stronger documentation or missing info—many are approved on second attempt.

5. Who handles the process at the clinic?
A Virtual Medical Assistant (VMA) gathers data, submits the PA, follows up, and coordinates with the provider and patient.

Disclaimer

For informational purposes only; not applicable to specific situations.

For tailored support and professional services,

Please contact Staffingly, Inc. at (800) 489-5877

Email : support@staffingly.com.

About This Blog : This Blog is brought to you by Staffingly, Inc., a trusted name in healthcare outsourcing. The team of skilled healthcare specialists and content creators is dedicated to improving the quality and efficiency of healthcare services. The team passionate about sharing knowledge through insightful articles, blogs, and other educational resources.